Antoine Harb is an Oncology physician affiliated with Wayne State College. OpenAlex indexes 22 publications with 213 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4383 Medical Dr
San Antonio, TX 782293307
Telephone
210-593-5700Provider last certified this registry record 8 Sept 2021.
Industry payments
71 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202512 payments
- E.R. Squibb & Sons, L.L.C.Program year202512 payments
- PFIZER INC.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
74.9%Iron, parenteral preparations74.6%Ferric carboxymaltose92%Ferric derisomaltose8%Part B, office-administered≥24 patientsFactor Xa inhibitor0.2%Eliquis55%Xarelto46%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
20.4%RANK Ligand Inhibitor20.3%Denosumab100%Part B, office-administered≥22 patientsXanthine oxidase inhibitor0.1%Allopurinol100%Part D≥13 patientsSensory organs
2.3%Corticosteroid2.3%Dexamethasone sodium phosphate98%Dexamethasone2%Part D + Part B≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract No. 365 Recent Trends of Female Representation in Interventional Radiology Training from 2008 to 2023: An Update
Journal of Vascular and Interventional Radiology
2025 - LB960 Awareness of nail melanoma among nail salon clients: A community outreach initiative
Journal of Investigative Dermatology
2024 - Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
Journal of Cancer Research and Clinical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”